Aggravation of diabetes, and incompletely deficient insulin secretion in a case with type 1 diabetes‐resistant human leukocyte antigen DRB1*15:02 treated with nivolumab

Anti‐programmed cell death‐1 (PD‐1) antibody therapy induces various adverse effects, especially in the endocrine system. Several cases of acute‐onset insulin‐dependent diabetes after anti‐PD‐1 antibody therapy have been reported. Many of these cases have a susceptible human leukocyte antigen (HLA)...

Descripción completa

Detalles Bibliográficos
Autores principales: Matsumura, Kimio, Nagasawa, Kaoru, Oshima, Yoichi, Kikuno, Shouta, Hayashi, Kyohei, Nishimura, Akihiro, Okubo, Minoru, Uruga, Hironori, Kishi, Kazuma, Kobayashi, Tetsuro, Mori, Yasumichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5835466/
https://www.ncbi.nlm.nih.gov/pubmed/28418115
http://dx.doi.org/10.1111/jdi.12679

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5835466/
https://www.ncbi.nlm.nih.gov/pubmed/28418115
http://dx.doi.org/10.1111/jdi.12679

Ejemplares similares